Research programme: vanilloid prodrugs - Vitality Biopharma

Drug Profile

Research programme: vanilloid prodrugs - Vitality Biopharma

Latest Information Update: 07 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Vitality Biopharma
  • Class Analgesics
  • Mechanism of Action TRPV1 receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Research Pain

Most Recent Events

  • 05 Apr 2017 Vitality Biopharma files for International patent protection for vanilloid prodrugs
  • 09 Nov 2016 Vitality files for patent protection with The Patent Cooperation Treaty (PCT) for vanniloid prodrugs
  • 24 Aug 2016 Early research in Pain in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top